Phillip Gross
CIK 1403413 · last filed 2017-09-28
Phillip Gross is a corporate insider who has filed 26 SEC Form 4 insider transactions across 8 companies since 2009. The most recent filing shows the insider sold $45.0M of CALA on Sep 28, 2017. Across all open-market trades the lifetime net is +$7.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $43.5M across reported positions. 134 SEC filings were submitted jointly with Robert Atchinson.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PBYI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
52ND FLOOR
BOSTON, MA 02116
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Calithera Biosciences, Inc. (CALA) Delisted | 10%+ Owner | 179,244 | $0.00 | $54 | -$7.82M | 5 | 2017-09-28 |
| PBYI | 10%+ Owner | 3,854,302 | $11.29 | $43.52M | -$39.33M | 3 | 2017-06-12 |
| MULESOFT, INC (MULE) Delisted | 10%+ Owner | 675,000 | — | — | -$3.13M | 1 | 2017-03-21 |
| Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | 10%+ Owner | 5,917,766 | — | — | $21.23M | 1 | 2015-08-24 |
| HeartWare International, Inc. (HTWR) Delisted | 10%+ Owner | 1,875,316 | — | — | -$69.91M | 1 | 2015-04-21 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | 10%+ Owner | 3,796,592 | — | — | $143.60M | 8 | 2013-09-26 |
| Sleep Number Corp (SCSS) Delisted | 10%+ Owner | 6,792,200 | — | — | -$51.78M | 3 | 2011-02-03 |
| BOULDER BRANDS, INC. (SMBL) Delisted | 10%+ Owner | 7,343,302 | — | — | $14.15M | 1 | 2009-03-26 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-09-28 | Calithera Biosciences, Inc. (CALA) Delisted | Sell (S) | −2,880,000 | -$45.04M | EDGAR |
| 2017-06-12 | PBYI | Sell (S) | −1,236,300 | -$99.29M | EDGAR |
| 2017-03-24 | Calithera Biosciences, Inc. (CALA) Delisted | Buy (P) | +2,439,020 | $25.00M | EDGAR |
| 2017-03-21 | MULESOFT, INC (MULE) Delisted | Sell (S) | −125,000 | -$3.13M | EDGAR |
| 2016-04-07 | — | Sell (S) | −24,110,635 | -$2.49M | |
| 2015-09-24 | Calithera Biosciences, Inc. (CALA) Delisted | Buy (P) | +534,840 | $3.22M | EDGAR |
| 2015-09-08 | Calithera Biosciences, Inc. (CALA) Delisted | Buy (P) | +451,500 | $2.68M | EDGAR |
| 2015-08-24 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Buy (P) | +1,500,000 | $21.23M | EDGAR |
| 2015-04-21 | HeartWare International, Inc. (HTWR) Delisted | Sell (S) | −866,335 | -$69.91M | EDGAR |
| 2014-10-15 | Calithera Biosciences, Inc. (CALA) Delisted | Buy (P) | +908,500 | $6.32M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.